首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer research

缩写:CANCER RES

ISSN:0008-5472

e-ISSN:1538-7445

IF/分区:22.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引12921条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Guannan Shu,Minyu Chen,Wuyuan Liao et al. Guannan Shu et al.
The tumor microenvironment (TME) in renal cell carcinomas (RCC) is marked by substantial immunosuppression and immune resistance despite having extensive T-cell infiltration. Elucidation of the mechanisms underlying immune evasion could hel...
Casey W Shuptrine,Yuhui Chen,Jayalakshmi Miriyala et al. Casey W Shuptrine et al.
Lipid nanoparticle (LNP)-encapsulated mRNA has been used for in vivo production of several secreted protein classes, such as IgG, and has enabled the development of personalized vaccines in oncology. Establishing the feasibility of deliveri...
Giulia Petroni,Serena Pillozzi,Lorenzo Antonuzzo Giulia Petroni
Tumor-associated tertiary lymphoid structures (TLS) have been associated with favorable clinical outcomes and response to immune checkpoint inhibitors in many cancer types, including non-small cell lung cancer. Although the detailed cellula...
Mengjia Song,Chaoqi Zhang,Shaoyan Cheng et al. Mengjia Song et al.
Neutrophil extracellular traps (NET), formed by the extracellular release of decondensed chromatin and granules, have been shown to promote tumor progression and metastasis. Tumor-associated neutrophils in hepatocellular carcinoma (HCC) are...
Aristotle Lau,John Blenis,Guillermo Burgos-Barragan Aristotle Lau
Serine metabolism plays a pivotal role in cancer, making it an appealing therapeutic target. Two recent studies published in Nature Metabolism and Science Translational Medicine uncovered novel players and therapeutic opportunities within t...
Bomiao Hu,Marc Wiesehöfer,Fernando J de Miguel et al. Bomiao Hu et al.
The majority of EGFR mutant lung adenocarcinomas respond well to EGFR tyrosine kinase inhibitors (TKI). However, most of these responses are partial, with drug-tolerant residual disease remaining even at the time of maximal response. This r...
Ruyi Zhang,Shanshan Li,Kelly Schippers et al. Ruyi Zhang et al.
AXIN1 is a major component of the β-catenin destruction complex and is frequently mutated in various cancer types, particularly liver cancers. Truncating AXIN1 mutations are recognized to encode a defective protein that leads to β-catenin...
Teifion Luckett,Maidinaimu Abudula,Lucy Ireland et al. Teifion Luckett et al.
Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic disease, yet effective treatments to inhibit PDAC metastasis are lacking. The rich PDAC tumor microenvironment plays a major role in disease progression. Macrophages are the mos...
Christine Alewine Christine Alewine
Although pancreatic cancer is a systemic disease that metastasizes early in its course, the signaling systems that promote this behavior remain incompletely understood. In this issue of Cancer Research, Luckett and colleagues identify a par...